98 related articles for article (PubMed ID: 30132370)
1. Underestimation of treatment effects in sequentially monitored clinical trials that did not stop early for benefit.
Marschner IC; Schou IM
Stat Methods Med Res; 2019; 28(10-11):3027-3041. PubMed ID: 30132370
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
Walter SD; Han H; Briel M; Guyatt GH
Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of clinical trials with early stopping: an investigation of potential bias.
Schou IM; Marschner IC
Stat Med; 2013 Dec; 32(28):4859-74. PubMed ID: 23824994
[TBL] [Abstract][Full Text] [Related]
4. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
Wang H; Rosner GL; Goodman SN
Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
[TBL] [Abstract][Full Text] [Related]
5. Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
Walter SD; Guyatt GH; Bassler D; Briel M; Ramsay T; Han HD
Stat Med; 2019 Jun; 38(14):2524-2543. PubMed ID: 30887553
[TBL] [Abstract][Full Text] [Related]
6. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
Shimura M; Gosho M; Hirakawa A
Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
[TBL] [Abstract][Full Text] [Related]
7. Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.
Shimura M; Maruo K; Gosho M
Pharm Stat; 2018 Sep; 17(5):400-413. PubMed ID: 29687592
[TBL] [Abstract][Full Text] [Related]
8. Estimation of the treatment effect following a clinical trial that stopped early for benefit.
Marschner IC; Schou M; Martin AJ
Stat Methods Med Res; 2022 Dec; 31(12):2456-2469. PubMed ID: 36065593
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Hazard Ratios in Oncology Clinical Trials Terminated Early for Superiority: A Systematic Review.
Shimura M; Nomura S; Wakabayashi M; Maruo K; Gosho M
JAMA Netw Open; 2020 Jun; 3(6):e208633. PubMed ID: 32573709
[TBL] [Abstract][Full Text] [Related]
10. Stopping clinical trials early for benefit: impact on estimation.
Freidlin B; Korn EL
Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
[TBL] [Abstract][Full Text] [Related]
11. Overestimation of benefit when clinical trials stop early: a simulation study.
Liu S; Garrison SR
Trials; 2022 Sep; 23(1):747. PubMed ID: 36064448
[TBL] [Abstract][Full Text] [Related]
12. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
[TBL] [Abstract][Full Text] [Related]
13. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
Zhang Z; Tang L; Liu C; Berger VW
Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
[TBL] [Abstract][Full Text] [Related]
14. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
15. Stopping rules and estimation problems in clinical trials.
Hughes MD; Pocock SJ
Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947
[TBL] [Abstract][Full Text] [Related]
16. Reducing overestimation of the treatment effect by interim analysis when designing clinical trials.
Shimura M
J Clin Pharm Ther; 2019 Apr; 44(2):243-248. PubMed ID: 30414384
[TBL] [Abstract][Full Text] [Related]
17. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
Chen YH; Li C; Lan KK
Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
[TBL] [Abstract][Full Text] [Related]
18. Accounting for interim safety monitoring of an adverse event upon termination of a clinical trial.
Dallas MJ
J Biopharm Stat; 2008; 18(4):631-8; discussion 439-45. PubMed ID: 18607795
[TBL] [Abstract][Full Text] [Related]
19. Stopping a trial early - and then what?
Wittes J
Clin Trials; 2012 Dec; 9(6):714-20. PubMed ID: 22879573
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
